Use of drugs with pharmacogenomics (PGx)-based dosing guidelines in a Danish cohort of persons with chronic kidney disease, both on dialysis and not on dialysis: Perspectives for prescribing optimization.

Niels Westergaard Morten Baltzer HoulindLona Louring ChristrupHelle Gybel Juul-LarsenCharlotte StrandhaveAnne Estrup Olesen

Published in: Basic & clinical pharmacology & toxicology (2024)

This study demonstrated that a substantial proportion of patients with CKD are exposed to drugs or drug combinations for which there exists AG related to PGx of CYP2D6, CYP2C19, CYP2C9 and SLCO1B1.

Keyphrases

chronic kidney disease
end stage renal disease
adverse drug
primary care
peritoneal dialysis
drug induced
quantum dots
emergency department
clinical practice
clinical decision support